Uncategorized
6 Analysts Assess Pacira BioSciences: What You Need To Know
Latest Ratings for PCRX Date Firm Action From To Feb 2022 Wedbush Maintains Outperform Feb 2022 HC Wainwright & Co. Maintains Buy Jan 2022 Barclays Maintains Overweight View More Analyst Ratings for PCRX View the Latest Analyst Ratings read more
8 Analysts Have This To Say About Crown Castle
Latest Ratings for CCI Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Jan 2022 Raymond James Upgrades Market Perform Outperform Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for CCI View the Latest Analyst Ratings read more
Deep Dive Into US Energy Stock: Analyst Perspectives (4 Ratings)
Latest Ratings for USEG Date Firm Action From To Jan 2022 EF Hutton Initiates Coverage On Buy May 2012 Ladenburg Thalmann Maintains Neutral May 2012 Global Hunter Securities Downgrades Buy Accumulate View More Analyst Ratings for USEG View the Latest Analyst Ratings read more
Wall Street Slashes Interest Rate Cut Bets After Jobs Data: Are Hikes Back On The Table?
Wall Street analysts are rethinking their interest rate forecasts after December’s strong jobs report shattered previous expectations. read more
Bitcoin Slides To $91,000 Ahead Of Upcoming Key Inflation Data
Bitcoin (CRYPTO: BTC) is entering a pivotal week, as concerns over a potentially overheating U.S. economy continue to drag down the apex cryptocurrency. read more
US Stock Futures Indicate Lower Opening On Monday After Last Week’s Steep Fall: Analyst Says It’s A ‘Buying Opportunity,’ But Market May Dip Further If This Happens
U.S. stock futures declined on Monday following Friday’s steep fall. Futures of all four major indices fell in premarket trade. read more
Asia And Europe Markets Fall, Dollar Hits New High – Global Markets Today While US Slept
US markets ended lower due to strong job data reigniting inflation fears and Fed rate adjustment expectations. Oil prices surged on US sanctions on Russia, while dollar rose on strong jobs data. read more